Dry Eye

All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.

The study found that the prosthetic replacement of the ocular surface ecosystem lenses were well tolerated in the delivery of non-preserved cyclosporine 0.05%.

The retrospective study investigated and analyzed the severity and frequency of ocular pain and factors affecting it among DED patients living in high altitudes above 2500 meters during the COVID-19 pandemic.

The dry eye drug has been assigned a PDUFA decision date of April 2, 2025, and the Aldeyra has chosen to expand their exclusive option agreement with AbbVie.

What we know and what we do not know…yet.

The lipid-containing lubricating drop established noninferiority in comfort when compared to non-lipid drops, and the lipid-containing group also exhibited statistically significant improvements in visual quality at both day 7 and day 30, highlighting the potential benefits of this formulation for patients.

Higher prevalence rates were also found among university students and administrative workers.

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 American Academy of Ophthalmology meeting.

There’s more to dry eye treatment than eye drops.

MeiboMetrics is scheduled to be available on several platforms starting in 2025.

Reproxalap was previously found to be statistically superior to vehicle for the primary endpoint of ocular discomfort (P=0.004) in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial.

Choosing the best lens is a puzzle that requires consideration of all the pieces.

The FDA and Palatin agreed on a clear regulatory path for PL9643 NDA submission in DED. The company hopes to start patient enrollment to start in the fourth quarter of calendar year 2024.

Understanding the latest innovative technologies.

Actionable tips to improve comfort and fit.

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, weigh in on meibomian gland dysfunction and dry eye disease what to consider when choosing symptom management options.

Adding a service to your practice can be scaled to your liking.

Results suggest higher exposures to lower temperatures and certain air pollutants could result in worsened ocular symptoms and increased tear osmolarity.

Vevizye was approved by the US FDA under the name Vevye in May 2023 for the treatment of moderate to severe dry eye disease.

The latest in market trends can offer insights into patient care.

The companies announced that they will be working to develop SGN’s micellar nanoparticle platform to be used with Eyenovia’s Optejet dispenser in a news release.

Increased pressure and inflammation require prompt treatment to avoid complications.

The collaboration agreement will allow the two companies to find a potential new treatment for chronic dry eye disease.

According to the company, the tuck-in acquisition will help expand its surgical presence in the United States and contribute to its leading position in dry eye.

The primary endpoint will be pain improvement as measured by visual analogue scale (VAS) compared to placebo.

The survey found that most participants may not know that their symptoms could be associated with eye dryness, including redness, fluctuating vision, a scratch, gritty, tired, or heavy feeling in the eye, or overall eye irritation.

Perfluorohexyloctane may slow evaporation to reduce dry eye.

Exploring strategies for effective management of a multifaceted condition.